JUVENILE DERMATOMYOSITIS (JDM)
Clinical trials for JUVENILE DERMATOMYOSITIS (JDM) explained in plain language.
Never miss a new study
Get alerted when new JUVENILE DERMATOMYOSITIS (JDM) trials appear
Sign up with your email to follow new studies for JUVENILE DERMATOMYOSITIS (JDM), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Fish oil fights rare muscle disease: new trial launches
Disease control Recruiting nowThis study tests whether omega-3 fatty acid supplements from fish oil can reduce disease activity in adults with dermatomyositis, a rare autoimmune condition causing muscle weakness and skin rashes. About 300 participants will take either fish oil capsules or a placebo for 6 mont…
Matched conditions: JUVENILE DERMATOMYOSITIS (JDM)
Phase: PHASE2 • Sponsor: National Institute of Environmental Health Sciences (NIEHS) • Aim: Disease control
Last updated May 26, 2026 05:14 UTC
-
Engineered immune cells take on childhood arthritis and autoimmune diseases
Disease control Recruiting nowThis study is testing a new treatment using specially engineered immune cells (CAR-T cells) in children aged 5 and older with severe rheumatic diseases like juvenile dermatomyositis, arthritis, systemic sclerosis, and Sjögren's syndrome that haven't improved with standard therapi…
Matched conditions: JUVENILE DERMATOMYOSITIS (JDM)
Phase: PHASE1 • Sponsor: Chongqing Precision Biotech Co., Ltd • Aim: Disease control
Last updated May 26, 2026 05:10 UTC